Pelican Cancer Foundation
10
5
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Improving Diagnosis and Treatment for Patients With Rectal Cancer
Role: collaborator
Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery
Role: collaborator
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Role: collaborator
Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers
Role: collaborator
Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits
Role: collaborator
Beyond TME Origins
Role: collaborator
Low Rectal Cancer Study (MERCURY II)
Role: collaborator
Mri IN STaging REctal Polyp Planes
Role: collaborator
Surgical Anatomy and 'Waisting' of the sIgmoid SpEcimen
Role: collaborator
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Role: collaborator
All 10 trials loaded